Display options
Share it on

Open Forum Infect Dis. 2021 Oct 29;8(12):ofab545. doi: 10.1093/ofid/ofab545. eCollection 2021 Dec.

On the Treatment of .

Open forum infectious diseases

Emily G McDonald, Guillaume Butler-Laporte, Olivier Del Corpo, Jimmy M Hsu, Alexander Lawandi, Julien Senecal, Zahra N Sohani, Matthew P Cheng, Todd C Lee

Affiliations

  1. Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Canada.
  2. Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Canada.
  3. Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada.
  4. Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada.
  5. Department of Critical Care Medicine, National Institutes of Health, Clinical Center, Bethesda, Maryland, USA.
  6. Department of Medicine, McGill University, Montréal, Canada.
  7. Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montréal, Canada.
  8. Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Canada.

PMID: 34988242 PMCID: PMC8694206 DOI: 10.1093/ofid/ofab545

[No abstract available.]

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Keywords: HIV; Pneumocystis jirovecii pneumonia; TMP-SMX; immunosuppressed; opportunistic infectious

Publication Types